can you stop taking glp 1 drugs What Happens When Patients GLP-1 Medications? People often don't understand what

Description

[DOI] [PubMed] [Google Scholar] 187.Chaston T.B., Dixon J.B., O'Brien P.E

Pancreatic -cell mass is significantly reduced by more than 50% in patients with T2DM, with lesser reductions already occurring in the prediabetes state (124)

Another meta-analysis, including 35 trials with GLP-1RAs investigating changes in lipid profile, found that treatment with GLP-1RAs leads to minor improvements in lipid profile and a modest effect on lipid metabolism (23)

[DOI] [PMC free article] [PubMed] [Google Scholar] 113.Wang X., Zhang H., Zhang Q., Guan M., Sheng S., Mo W., Zou M., Li J., Bi J., Tang X

However, due to its indicated short half-live, GLP-1 peptide is an unattractive therapeutic agent on itself, which stimulated the quest for GLP-1 based compounds with better bioavailability